Longer Lives for Certain Stage Four Cancer Patients
Two researchers have found a way to extend the life expectancy of a subset of Stage Four lung cancer patients who previously didn’t respond to chemotherapy alone.
Two researchers have found a way to extend the life expectancy of a subset of Stage Four lung cancer patients who previously didn’t respond to chemotherapy alone. Their work identified two dozen patients among the roughly 30 percent of individuals with Stage Four lung cancer whose tumors did not respond to standard chemotherapy. Believing that the cancer likely had not yet spread to other organs, the doctors delivered concentrated doses of radiation to specific tumors. Over a six-year period, UT Southwestern researchers Robert Timmerman and Puneeth Iyengar found they were able to significantly extend the life expectancy of this group of patients. (D Healthcare Daily)
Information about the authors
Quality journalism doesn't come free
Perhaps it goes without saying — but producing quality journalism isn't cheap. At a time when newsroom resources and revenue across the country are declining, The Texas Tribune remains committed to sustaining our mission: creating a more engaged and informed Texas with every story we cover, every event we convene and every newsletter we send. As a nonprofit newsroom, we rely on members to help keep our stories free and our events open to the public. Do you value our journalism? Show us with your support.Yes, I'll donate today